Αρχειοθήκη ιστολογίου

Σάββατο 24 Ιουνίου 2017

Targeting STAT3 with silibinin to improve cancer therapeutics

The effectiveness of cancer therapy is one of the main challenges in cancer treatment. Cancer resistance to chemotherapy, radiotherapy, and targeted therapies may be inherent or acquired, and ultimately drives tumor relapse and poor treatment outcomes. In many cases, advanced cancer patients eventually fail to respond to treatment or experience tumor relapse due to the expansion of drug-resistant tumor cell populations [1]. (Source: Cancer Treatment Reviews)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2s85nPX
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader